FLUO Share Price Performance
SEK 35.00
-9.95 (-22.14%)
Price SEK 35.00
Share Pricen/a
FluoGuide A/S Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
FLUO Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
FluoGuide A/S Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 25, 2026
- -2.15
- 100.00%
- 7,391.58%
- -1,109.9%
About FLUO
- Founded
- 2018
- Employees
- 8
- CEO
- WebsiteView website
FluoGuide A/S, a clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark. Its lead product candidate is FG001, which is in Phase IIa and IIb for the treatment of high-grade glioma; Phase II clinical trial for the treatment of lung cancer, and head and neck cancer. The company has a collaboration agreement with ZEISS Medical Technologies for the development of FG001 for tumor imaging and surgical margins assessment for head and neck cancer. FluoGuide A/S was incorporated in 2018 and is headquartered in Copenhagen, Denmark.
